Inulin for Infections in the Intensive Care Unit

PHASE2CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

November 21, 2023

Study Completion Date

July 23, 2024

Conditions
Antibiotic Resistant InfectionNosocomial InfectionPathogen TransmissionNutrition DisordersCritical IllnessSepsis
Interventions
DRUG

Inulin Oral Suspension

Inulin powder, derived from chicory root and re-suspended in 250cc water Dosage will be either 8g twice a day or 16g twice a day - dissolved in 250cc sterile water, given oral or via enteric tube

DRUG

Placebo Oral Suspension

250cc sterile water alone, given twice daily a sweetener is added to the water to create identical flavor

DRUG

Broad-spectrum antibiotics

Standard of care treatment for infections

Trial Locations (1)

10023

Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT03865706 - Inulin for Infections in the Intensive Care Unit | Biotech Hunter | Biotech Hunter